Binding of high-avidity anti-β2-glycoprotein I antibodies

被引:14
|
作者
Cucnik, S
Kveder, T
Rozman, B
Bozic, B
机构
[1] Univ Ljubljana, Med Ctr, Dept Rheumatol, Ljubljana 1000, Slovenia
[2] Univ Ljubljana, Fac Pharm, Ljubljana, Slovenia
关键词
anti-beta 2-glycoprotein I antibodies; Fab fragments; avidity; affinity; antiphospholipid syndrome; systemic lupus erythematosus;
D O I
10.1093/rheumatology/keh349
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. We studied the influence of different binding conditions on the interaction between high- or low-avidity IgG anti-beta(2)-glycoprotein I antibodies (anti-beta(2)-GPI) and beta(2)-GPI, which was either free in solution or bound to microtitre plates or nitrocellulose membranes. Methods. Sera from 30 patients with antiphospholipid syndrome and/or systemic lupus erythematosus were selected on the basis of anti-beta(2)-GPI positivity. Avidity of IgG anti-beta(2)-GPI was determined by chaotropic ELISA, using increased NaCl concentration during the antibody binding. Immunodetection on nitrocellulose membrane followed reducing or non-reducing sodium dodecyl sulphate-polyacrylamide gel electrophoresis (PAGE) of beta(2)-GPI. In converted, non-reducing PAGE, the preparation with high-affinity Fab fragments (obtained by papain digestion) was subjected to electrophoresis, while purified beta(2)-GPI was used as the sample in immunodetection. Results. Anti-beta(2)-GPI antibodies of high, low or heterogeneous (low and high) avidity were found in 5/30, 9/30 and 16/30 sera, respectively. The density of beta(2)-GPI, which was 20-30 times higher on the nitrocellulose membrane than on the surface of ELISA plates, was not sufficient for the recognition of the antigen by anti-beta(2)-GPI: 2/5 high-avidity samples reacted only with non-reduced beta(2)-GPI, 3/9 low-avidity samples recognized only denatured and reduced beta(2)-GPI, and 1/16 samples with heterogeneous-avidity antibodies reacted with reduced and non-reduced beta(2)-GPI. Conclusions. Our results suggest that neither high density of the antigen nor high avidity of the antibodies (or Fab fragments) alone was sufficient for the binding of anti-beta(2)-GPI to beta(2)-GPI. Some conformational modifications and, consequently, exposed neo-epitopes are required for the recognition of beta(2)-GPI by polyclonal anti-beta(2)-GPI antibodies.
引用
收藏
页码:1353 / 1356
页数:4
相关论文
共 50 条
  • [21] Heterogeneous behavior of anti-β2-glycoprotein I antibodies on various commercially available enzyme immunoassay plates coated with β2-glycoprotein I
    Tsutsumi, A
    Ichikawa, K
    Matsuura, E
    Sawada, KI
    Koike, T
    JOURNAL OF RHEUMATOLOGY, 2000, 27 (02) : 391 - 396
  • [22] IgG antibodies to plasminogen and their relationship to IgG anti-β2-glycoprotein 1 antibodies and thrombosis
    Bu, Chunya
    Li, Zhihuan
    Zhang, Chune
    Gao, Lei
    Cai, Guoping
    CLINICAL RHEUMATOLOGY, 2008, 27 (02) : 171 - 178
  • [23] IgG antibodies to plasminogen and their relationship to IgG anti-β2-glycoprotein 1 antibodies and thrombosis
    Chunya Bu
    Zhihuan Li
    Chune Zhang
    Lei Gao
    Guoping Cai
    Clinical Rheumatology, 2008, 27 : 171 - 178
  • [24] Avidity of anti-beta-2-glycoprotein I antibodies
    Bozic, B
    Cucnik, S
    Kveder, T
    Rozman, B
    AUTOIMMUNITY REVIEWS, 2005, 4 (05) : 303 - 308
  • [25] Anti-β2-glycoprotein I antibodies are associated with pregnancy loss in women with the lupus anticoagulant
    Sailer, Thomas
    Zoghlami, Claudia
    Kurz, Christine
    Rumpold, Helmut
    Quehenberger, Peter
    Panzer, Simon
    Pabinger, Ingrid
    THROMBOSIS AND HAEMOSTASIS, 2006, 95 (05) : 796 - 801
  • [26] Correlation between β2-glycoprotein I valine/leucine247 polymorphism and anti-β2-glycoprotein I antibodies in patients with primary antiphospholipid syndrome
    Atsumi, T
    Tsutsumi, A
    Amengual, O
    Khamashta, MA
    Hughes, GRV
    Miyoshi, Y
    Ichikawa, K
    Koike, T
    RHEUMATOLOGY, 1999, 38 (08) : 721 - 723
  • [27] Anti-cardiolipin and anti-β2-glycoprotein I antibodies: normal reference ranges in northwestern Italy
    Montaruli, B.
    De Luna, E.
    Mengozzi, G.
    Molinari, F.
    Napolitano, E.
    Napoli, P.
    Nicolo, C.
    Romito, A.
    Stella, S.
    Bazzan, M.
    Bertero, M. T.
    Carignola, R.
    Marchese, C.
    LUPUS, 2012, 21 (07) : 799 - 801
  • [28] Anti-cardiolipin and anti-β2-glycoprotein I antibodies -: Performance of new commercial ELISA kits
    Andreoli, Laura
    Malacarne, Fabio
    Ceribelli, Angela
    Kutschera, Iris
    Tincani, Angela
    AUTOIMMUNITY, PART A: BASIC PRINCIPLES AND NEW DIAGNOSTIC TOOLS, 2007, 1109 : 531 - 537
  • [29] Budding, vesiculation and permeabilization of phospholipid membranes -: evidence for a feasible physiologic role of β2-glycoprotein I and pathogenic actions of anti-β2-glycoprotein I antibodies
    Ambrozic, A
    Bozic, B
    Kveder, T
    Majhenc, J
    Arrigler, V
    Svetina, S
    Rozman, B
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2005, 1740 (01): : 38 - 44
  • [30] Study of β2-Glycoprotein I Polymorphisms in Patients With Chronic Renal Failure as a Predisposing Factor for the Development of Anti-β2-Glycoprotein I Auto-Antibodies
    Serrano, M.
    Cabrera-Marante, O.
    Martinez-Flores, J. A.
    Morales, P.
    Perez, D.
    Mora, S.
    Garcia, F.
    Gonzalez, E.
    Paz-Artal, E.
    Morales, J. M.
    Serrano, A.
    TRANSPLANTATION PROCEEDINGS, 2016, 48 (09) : 2876 - 2879